Hepatitis C Direct Antiviral Drugs and Hepatic Decompensation in Patients With Advanced Cirrhosis: Culprit or Innocent Bystander?

Digestive Diseases and Sciences- United States

doi 10.1007/s10620-015-3535-x

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Leukotriene Receptor Antagonist Therapy and Churg-Strauss Syndrome: Culprit or Innocent Bystander?

Thorax
PulmonaryRespiratory Medicine
2008English

Clinical Outcomes of Direct-Acting Antiviral Therapy in Patients With Compensated Hepatitis C Virus-Related Cirrhosis

Hepatoma Research
2017English

Direct-Acting Antiviral Drugs and Hepatitis C Virus: A Therapeutic Revolution?

Cancer
Cancer ResearchOncology
2015English

Antiviral Treatment in Patients With Hepatitis C Virus-Related Cirrhosis Awaiting Liver Transplantation

Therapeutics and Clinical Risk Management
2008English

Letter: Should Direct-Acting Antiviral Drugs Be Used Concomitantly With Chemotherapeutic Drugs in Hepatitis C Virus-Infected Patients With Cancer? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2016English

Systematic Review: Current Concepts and Challenges for the Direct-Acting Antiviral Era in Hepatitis C Cirrhosis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Sofosbuvir-Velpatasvir-Voxilaprevir With or Without Ribavirin in Direct-Acting Antiviral-Experienced Patients With Genotype 1 Hepatitis C Virus

Hepatology
MedicineHepatology
2017English

TDP-43 Is a Culprit in Human Neurodegeneration, and Not Just an Innocent Bystander

Mammalian Genome
Genetics
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy